CIGNA PATHWELL

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

CI

Owner Name

Type: Organization / Corporation

Address

300 Bellevue Parkway
Willmington, DE 19809

Critical Dates

First Use Date

Jun 1, 2022

Filing Date

Sep 21, 2021

Registration Date

Feb 25, 2025

Mark Descriptions

Services

Class 35
Cost management for the healthcare benefit and prescription drug benefit plans of others in the field of pharmaceuticals; business services, namely, pharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others...
Class 36
Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefits, in-network coverage and pharmacy benefits...
Class 44
Advisory services and consultancy regarding healthcare; healthcare services, namely, wellness and disease management programs for patients; health care services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance and...

Mark Elements

Text Mark
CIGNA PATHWELL
Category
Service Mark
Standard Characters
Yes
Color Claim
No
Related Registrations
2563544
4298899
4298900
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Jun 1, 2022

Filing Date

Sep 21, 2021

Publication Date

Feb 7, 2023

Registration Date

Feb 25, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 07:17 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The service mark CIGNA PATHWELL covers cost management and consulting for healthcare benefit and prescription drug plans, pharmaceutical utilization review, and business analysis in class 035; pharmacy benefit management, insurance underwriting, and claims administration for prescription drug plans in class 036; and healthcare advisory, wellness, disease management programs, and medical information services in class 044, with first use in commerce June 1, 2022. It is owned by Cigna Intellectual Property, Inc., a Delaware corporation located at 300 Bellevue Parkway, Wilmington, Delaware 19809. The mark is registered on the Principal Register effective February 25, 2025. It claims priority to prior registrations 2563544, 4298899, and 4298900, with no active oppositions or legal proceedings.

Recent Activity

Filed September 21, 2021, the application received a non-final office action July 5, 2022, to which applicant responded December 15, 2022, leading to approval and publication for opposition February 7, 2023. After notice of allowance April 4, 2023, and two extensions of time to file statement of use, applicant submitted the statement October 3, 2024, which was accepted February 5, 2025, resulting in registration February 25, 2025.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 07:17 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.